Boston Scientific (BSX) Cash from Investing Activities Growth (1y) (2010 - 2026)
Boston Scientific (BSX) Cash from Investing Activities Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | -15.64% |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | -514.42% |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | -87.14% |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | -73.71% |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | -12.26% |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 618.55% |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 48.43% |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 91.33% |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 0.00% |
| 10 | Zimmer Biomet Holdings | 19.36 Bn | 18.95 Bn | 1.54 Bn | 86.22% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -73.71% |
| Mar 31, 2026 | -18.20% |
| Dec 31, 2025 | 86.18% |
| Sep 30, 2025 | 64.82% |
| Jun 30, 2025 | -315.50% |
| Mar 31, 2025 | -75.44% |
| Dec 31, 2024 | -251.76% |
| Sep 30, 2024 | -624.37% |
| Jun 30, 2024 | 67.74% |
| Mar 31, 2024 | 41.12% |
| Dec 31, 2023 | -475.41% |
| Sep 30, 2023 | 12.44% |
| Jun 30, 2023 | -2,796.55% |
| Mar 31, 2023 | 69.25% |
| Dec 31, 2022 | 60.30% |
| Sep 30, 2022 | 81.36% |
| Mar 31, 2022 | -2,316.90% |
| Dec 31, 2021 | -213.61% |
| Sep 30, 2021 | -835.66% |
| Mar 31, 2021 | 193.42% |